PVLA
Palvella Therapeutics
PVLA
PVLA
27 hedge funds and large institutions have $50.4M invested in Palvella Therapeutics in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.02% less ownership
Funds ownership: 0.59% → 0.56% (-0.02%)
Holders
27
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$661K | |
| 2 | +$494K | |
| 3 | +$475K | |
| 4 |
BlackRock
New York
|
+$233K |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$200K |
Top Sellers
| 1 | -$1.81M | |
| 2 | -$535K | |
| 3 | -$441K | |
| 4 |
OC
Oppenheimer & Co
New York
|
-$23K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$20K |